Skip to main content
. 2019 Oct 9;5:570–578. doi: 10.1016/j.trci.2019.08.008

Table 2.

Comparison of different optical coherence tomography analysis between patients and control eyes; mild cognitive impairment (MCI) patients and control eyes and Alzheimer's disease (AD) patients and controls

Variables Patients (N = 63) Controls (N = 63) P MCI (N = 51) Controls (N = 51) P AD (N = 12) Controls (N = 12) P
Average RNFL thickness 97.7 (11,6) 99.9 (8.2) .004 93.7 (12.5) 99.5 (8.1) .005 99.4 (5.1) 102.0 (9.3) .482
RNFL temporal 66.5 (9.0) 71.3 (10.2) .028 65.9 (9.4) 70.9 (10.7) .050 70.0 (6.2) 74.1 (5.8) .312
RNFL temporal-superior 118.8 (16.6) 127.4 (17.4) .019 119.5 (16.3) 127.3 (17.3) .062 115.0 (19.0) 128.3 (19.1) .080
RNFL temporal-inferior 139.4 (20.8) 149.8 (15.8) .004 139.5 (22.0) 149.0 (15.1) .018 138.7 (10.4) 153.7 (19.6) .062
RNFL nasal 80.5 (17.8) 81.7 (15.2) .673 79.6 (18.3) 80.1 (15.5) .875 85.2 (14.4) 90.4 (10.5) .386
RNFL nasal-superior 111.3 (22.6) 117.3 (25.8) .201 108.9 (22.1) 117.4 (25.5) .090 124.3 (22.1) 166.6 (20.1) .571
RNFL nasal-inferior 105.5 (29.6) 114.0 (18.0) .062 109.7 (27.4) 114.5 (16.8) .275 83.0 (33.1) 111.4 (24.9) .100
Average BMO-MRW 290.3 (54.1) 303.5 (54.6) .263 281.9 (49.9) 309.4 (54.9) .027 326.8 (58.8) 278.8 (47.3) .106
BMO-MRW temporal 208.9 (49.9) 203.3 (43.5) .649 207.7 (52.8) 205.4 (46.1) .878 214.2 (27.6) 193.8 (30.5) .012
BMO-MRW temporal-superior 272.4 (64.2) 291.9 (49.8) .231 272.2 (70.1) 295.2 (53.6) .240 273.3 (28.8) 276.8 (24.7) .848
BMO-MRW temporal-inferior 286.2 (67.5) 315.6 (64.6) .131 277.6 (69.7) 317.4 (64.9) .091 324.6 (41.2) 307.6 (68.8) .267
BMO-MRW nasal 319.8 (65.5) 325.2 (60.4) .735 305.5 (55.2) 327.3 (61.7) .202 383.6 (74.9) 315.5 (58.7) .095
BMO-MRW nasal-superior 328.0 (75.0) 347.2 (54.7) .323 322.4 (74.9) 348.1 (53.2) .237 353.0 (76.3) 343.3 (66.5) .845
BMO-MRW nasal-inferior 348.3 (63.6) 371.0 (59.1) .138 342.2 (61.8) 372.6 (61.3) .089 375.6 (69.8) 363.8 (52.0) .657
GCL superior 47.5 (9.1) 51.8 (5.6) .006 48.3 (7.1) 51.0 (5.5) .057 44.3 (14.9) 55.2 (5.4) .050
GCL inferior 46.5 (9.8) 50.9 (6.0) .008 47.1 (8.5) 50.2 (6.1) .052 44.2 (14.4) 53.7 (4.5) .078
GCL temporal 41.7 (9.5) 46.7 (5.8) .002 42.2 (8.4) 46.1 (6.1) .015 39.6 (13.4) 49.1 (4.3) .074
GCL nasal 46.5 (9.3) 50.5 (6.4) .014 47.3 (7.8) 50.1 (6.6) .089 43.3 (14.2) 52.7 (5.1) .078
IPL superior 39.0 (4.3) 41.1 (3.6) .011 39.1 (4.4) 40.5 (3.2) .097 38.8 (4.1) 44.0 (3.9) .026
IPL inferior 38.6 (4.3) 40.1 (3.7) .066 38.5 (4.5) 39.6 (3.7) .268 38.8 (2.9) 42.4 (2.5) .007
IPL temporal 39.6 (4.1) 40.8 (3.6) .111 39.6 (4.1) 40.3 (3.3) .421 39.2 (3.8) 43.0 (4.1) .044
IPL nasal 39.8 (3.9) 41.4 (3.5) .025 39.7 (4.1) 41.0 (3.4) .138 39.7 (3.3) 43.3 (3.0) .009
ONL superior 63.4 (11.7) 68.9 (10.7) .010 63.3 (11.6) 68.1 (11.3) .048 63.5 (12.3) 72.7 (5.8) .058
ONL inferior 60.7 (15.2) 63.5 (12.2) .344 60.3 (14.5) 63.5 (12.7) .296 62.5 (18.4) 63.1 (10.0) .947
ONL temporal 69.4 (10.2) 72.7 (10.3) .072 68.6 (10.5) 72.2 (10.8) .100 72.9 (7.8) 75.0 (6.7) .442
ONL nasal 68.3 (15.3) 72.2 (11.8) .156 68.2 (15.1) 72.2 (11.6) .166 68.3 (16.9) 72.0 (13.2) .676

NOTE. Data for quantitative variables are shown as mean (standard deviation). Analysis was performed using paired Student's t-test for dependent samples.

Patients means mild cognitive impairment (MCI) and Alzheimer disease (AD) patients altogether.

Abbreviations: RNFL, retinal nerve fiber layer; GCL, ganglion cell layer; BMO-MRW, Bruch's membrane opening–minimum rim width; IPL. inner plexiform layer; ONL, outer nuclear layer.

P value < .005.